Stock Titan Deals and strategy
BioNexus Gene Lab Corp (BGLC) CEO reports 338,709-share award and 11.5% stake
BioNexus Gene Lab Corp (BGLC) CEO Su-Leng Tan Lee was granted 338,709 shares as a fully vested Other Stock-Based Award under the company’s 2025 Equity Incentive Plan for completed services. This award gives her beneficial ownership of approximately 11.5% of the outstanding common stock, valued at $1.55 per share for plan purposes, totaling $524,998.95. Tan Lee holds sole …